The Peptide Moment: How FDA's Regulatory Reversal Creates Risk and Opportunity for Venture Capital and Private Equity Guidepost Solutions FDA May Reverse Ban on 14 PeptidesWhat It Means for Your Beauty Routine Allure Is Your Peptide Store Website FDA Aligned? onPoint Studio Web Design and Development Services In a major policy shift, the U.S. Food and Drug Administration is reconsidering restrictions on several controversial peptides, including trending compounds like BPC 157 and Melanotan II. The move comes as demand for